Related Experiment Videos
Multistage carcinogenesis and the fraction at risk
Stephan Morgenthaler1, Pablo Herrero, William G Thilly
1Swiss Federal Institute of Technology (EPFL), SB/IMA, 1015 Lausanne, Switzerland. stephan.morgenthaler@epfl.ch
Journal of Mathematical Biology
|November 19, 2004
Summary
This study enhances multistage carcinogenesis models to include population heterogeneity. It accounts for individual genetic and environmental factors influencing cancer development, offering a more realistic approach to cancer evolution research.
Area of Science:
- Oncology
- Mathematical Biology
- Population Genetics
Background:
- Multistage carcinogenesis models explain cancer progression through cellular evolution.
- These models typically assume homogeneous populations and random genetic events.
- Individual variability in genetic and environmental factors is known to influence cancer risk.
Purpose of the Study:
- To generalize existing multistage carcinogenesis models.
- To incorporate individual heterogeneity within populations.
- To account for environmental and genetic variability in cancer development.
Main Methods:
- Development of a generalized mathematical framework for carcinogenesis.
- Integration of population heterogeneity into existing models.
- Simulation and analysis of cancer progression in diverse populations.
Main Results:
- The generalized model demonstrates the impact of individual variability on cancer progression dynamics.
- Heterogeneity significantly alters predicted cancer incidence and evolution trajectories.
- The study provides a more nuanced understanding of cancer development in real-world populations.
Conclusions:
- Existing carcinogenesis models may underestimate cancer risk due to population homogeneity assumptions.
- Incorporating individual variability is crucial for accurate cancer modeling.
- This generalized approach offers a foundation for personalized cancer risk assessment and prevention strategies.
Related Concept Videos
Mutagenicity and Carcinogenicity
1.8K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
Cancers Originate from Somatic Mutations in a Single Cell
14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K
Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancer Survival Analysis
629
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
629
Skin Cancer
5.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K